Status:
COMPLETED
Prospective Survey of CMV, Herpesviruses Infections and Diseases in Allo-HSCT
Lead Sponsor:
Gruppo Italiano Trapianto di Midollo Osseo
Collaborating Sponsors:
Azienda Policlinico Umberto I
Conditions:
Hematologic Diseases
Stem Cell Transplant Complications
Eligibility:
All Genders
Brief Summary
Prospective observational study of epidemiological surveillance, multicenter, non-profit, spontaneous, Italian with objective to describe the incidence of CMV infections and diseases in adult and pedi...
Detailed Description
This is a prospective observational study of epidemiological surveillance, multicenter, non-profit, spontaneous, italian on patients submitted to allogeneic haematopoietic stem cell transplantation or...
Eligibility Criteria
Inclusion
- Prospective observational study of epidemiological surveillance, multicenter, non-profit, spontaneous, Italian with objective to describe the incidence of CMV infections and diseases in adult and pediatric patients undergoing allo-HSCT during the first 6 months from transplant. This study will evaluate approximately 1500 subjects, with competitive enrolment from GITMO investigational centers.
Exclusion
- Absence of consent Written information
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
1310 Patients enrolled
Trial Details
Trial ID
NCT04412811
Start Date
January 1 2021
End Date
March 31 2023
Last Update
January 6 2025
Active Locations (50)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale San Carlo
Potenza, Italy, Italy
2
Policlinico GB Rossi
Verona, Italy, Italy
3
UO Ematologia e TMO - Ospedale C. Panico
Tricase, Lecce, Italy
4
A.O.U. Policlinico Federico II
Napoli, Napoli, Italy